Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management

Jordan Heath1, Larry Hartzell2, Claire Putt3,4

  • 1Boone Hospital Center, Columbia, MO, USA.

Insights

Pediatric chronic rhinosinusitis (CRS) is a common childhood illness diagnosed after 3 months of persistent sinus symptoms. This review covers its differential diagnosis and current/emerging treatments for better management.

Area of Science:

  • Pediatric Otolaryngology
  • Allergy and Immunology
  • Infectious Diseases

Background:

  • Pediatric chronic rhinosinusitis (CRS) is a prevalent condition causing significant morbidity in children.
  • Diagnosis is based on sinus symptoms persisting over 3 months despite medical treatment.
  • Underlying causes include viral infections, allergies, and anatomical issues leading to osteomeatal complex obstruction.

Purpose of the Study:

  • To review the differential diagnosis of pediatric CRS, encompassing various phenotypes and endotypes.
  • To detail current and emerging treatment strategies for pediatric CRS.
  • To provide an updated consensus on the prevalence and management of this condition in children.

Main Methods:

  • Literature review of recent survey studies and clinical findings.
  • Analysis of differential diagnoses including infectious, eosinophilic, allergic, and immunodeficiency-related conditions.
  • Examination of established and novel therapeutic interventions.

Main Results:

  • Pediatric CRS presents with diverse phenotypes and endotypes, complicating diagnosis and management.
  • Key differential diagnoses include non-eosinophilic/infectious CRS, eosinophilic CRS with/without polyps, allergic fungal sinusitis, aspirin-exacerbated respiratory disease, primary immunodeficiency, and mucociliary clearance disorders.
  • Current treatments are detailed, alongside emerging options like anti-immunoglobulin E, anti-interleukin-5, and anti-interleukin-4 receptor alpha therapies.

Conclusions:

  • Accurate diagnosis of pediatric CRS requires consideration of multiple underlying factors and phenotypes.
  • A comprehensive approach to management, incorporating both standard and novel therapies, is essential.
  • Further research into emerging treatments holds promise for improved outcomes in pediatric CRS.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
265
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
220
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
369
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
352
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.7K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312